About Us

WHO WE ARE
Genesis Research is a global Life Sciences research and consulting company dedicated to providing End-to-End Evidence Development, Management, and Communication services.

WHAT WE DO
Healthcare evidence can be categorized as foundational, demonstrative or oppositional in nature, and we take that holistic view to our clients. Through this unique perspective, we bring customized engagement approaches to support our clients. Our passion is working with our clients collaboratively, providing support for both the planned and unplanned initiatives that define the world of evidence in the 21st century.

ZERO

Projects we outsource

3

New team members in 2018

20

Areas of therapeutic
expertise

WHAT WE OFFER


OUR CLIENTS

Through our unique engagement approach we support our Life Sciences clients with research and consulting services.

Pharmaceutical and Biotechnology
Genesis provides research support to deliver evidence to satisfy regulatory requirements, payer requests, safety analyses and economic arguments throughout the product life-cycle.
As a leader in evidence development and communication, we also support our clients with unique services such as rapid response analytics, outcomes simulation, and payer data collaboration.

Medical Devices and Diagnostics
Genesis provides a range of evidence support to the Medical device, Diagnostic, and Nutritional Product market. From EMR data analytics to hospital models and outcomes analyzers, the opportunity to communicate the value of interventions is customized for the medical device and diagnostics industry.
Real World Evidence policy for medical device and diagnostic products allows for novel evidence development and communication activities. To this end, Genesis has expertise in industry best support focused on emerging safety signals, comparative effectiveness and a differentiated value story.

CLIENT TESTIMONIALS:

" It is always a pleasure to work with Genesis - they are a true partner "

" Genesis is a provider of innovative solutions "

" Genesis is an organization where I have direct contact with the experts at my convenience "

" Genesis provides the best data visualization in the industry "

Case Studies

OUTCOMES SIMULATION

Simulation of Patient-Treatment effect for various experimental cohorts

Evidence Mapping and Value Platforms

Centralized evidence resource for multiple markets

Data Analytics Support

Support for an advanced data analytic capability

Data Analytics Partnership Plus Data Analytics Platform Technology

Rapid Response RWE

Rapid Literature Review and Data Visualization

Crystallizing data for multiple stakeholders

European Database Analysis

With the goal of high profile publication

Economic model
with Graphic User Interface

An economic model that tells a compelling story

Hospital Database Analysis

Leverage rich clinical data from leading providers

GVD Rescue

Taking data and making it easy to understand

Meta Analysis and Data Visualization

Complex evidence optimized for market access strategy and lanuch success

Emerging Safety Signals

Real time safety analysis and regulatory engagement

Automated Chart Development for Treatment Pattern Analysis

Leveraging content and healthcare IT expertise

News

Sort by

Management Team

Genesis' core team of industry leaders share passion and commitment to building lasting relationships with our clients

STEVE ARIKIAN, MD

Steve has over 25 years of experience in Epidemiology and Outcomes Research, including academic appointments at Columbia University, the University of Kentucky and the University of Toronto, as well as tenure in Big Pharma and Consulting. His interests include design and implementation of large-scale database analyses, economic modeling and MetaResearch. He has designed and implemented research projects in the United States, Canada, Latin America, Europe and Australasia.
A co-founder of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Steve is widely published in the peer-reviewed literature, is a referee for numerous professional journals, and has been a frequent speaker at industry and trade group sponsored meetings on topics including Database Analytics, Pharmacoepidemiology, MetaResearch, Formulary Management, Pharmaceutical Pricing, and evaluating Product Value.

STEVE ARIKIAN, MD
Managing Director & Chief Executive Officer

FRANK A. CORVINO, PHD

Specializing in epidemiology and biostatistics, Dr. Corvino consistently leverages his knowledge of real world data sources to best fit the clinical and economic outcomes of each particular analysis. His real world data expertise includes chart reviews, registry data, clinical datasets, claims and electronic health records.

FRANK A. CORVINO, PHD
Managing Partner & Chief Operating Officer

MARKO ZIVKOVIC, PHD

Dr. Zivkovic manages a team of analysts and plays a pivotal role in the development of technology systems that support and leverage data analytics. Dr. Zivkovic has a particular interest in the development of predictive models and machine learning to facilitate the patient prioritization and clinical insights critical to healthcare management.

MARKO ZIVKOVIC, PHD
Partner & Chief Scientific Officer

Julie Locklear, PharmD, MBA

Dr. Locklear Directs and manages a team of scientists, biostatisticians, and programmers to implement strategic client initiatives. in Health Economics & Outcomes Research, including data analytics, health economic modeling, simulation, and scientific communications; Market Access solutions and deliverables; Business Development evaluations; Regulatory support and C-suite strategic and innovative solutions.
Dr. Locklear was Vice President and Head of Health Economics and Outcomes Research at EMD Serono, the biopharmaceutical division of Merck KGaA Darmstadt, Germany, where she was responsible for establishing and building the US Health Economics & Outcomes Research team within the Medical Affairs organization. She also previously served as Global Payer Evidence Director at AstraZeneca, and as an Associate Director of US Health Economics and Outcomes Research at Janssen Pharmaceutica.

JULIE LOCKLEAR, PharmD, MBA
Managing Partner

Michael J. Di Costanzo Jr.

Michael has served as Chief Financial Officer of Genesis Research since 2010, where he directs all financial operations including corporate accounting, financial planning and analysis, internal audit, tax, treasury, corporate development, insurance, and real estate. Born and raised in New York, Mike received his CPA degree from Fordham University and is an expert in Corporate, Partnership and Individual Taxation. His broad range of experience stretches from multi-million dollar companies to entrepreneurial startups.

MICHAEL J. DI COSTANZO JR.
Chief Financial Officer

MICHAEL LIVINGSTONE

Michael has been with the Genesis team since 2011, with increasing levels of responsibility, fostering company growth on a number of ongoing client relationships. As the Director of Operations, Michael works on talent acquisition, introduction of executable strategies and tactics to harmonize business practices with commercial goals and consolidation of cross-functional teams to deliver client solutions.

MICHAEL LIVINGSTONE
Director of Operations

careers

Our team includes graduates from the world’s top universities, accomplished professionals, physicists and epidemiologists, specialists and generalists; we are always in search of the right people to join our team.
WE ARE LOOKING FOR
Creative, brave and enthusiastic professionals to join our growing team and help us further push the boundaries of our research.

Senior Analyst
Research Analyst

Contact Us

Email
info@genesisrg.com

Phone
T+1 888 503 2680

Address
5 Marine View Plaza, Suite 312
Hoboken NJ 07030